{"DataElement":{"publicId":"2725825","version":"2","preferredName":"Positron Emission Tomography (PET) Assessment Disease Response Disease Response Category","preferredDefinition":"The final result of a Positron Emission Tomography (PET) in determinating the extent of  cancer that continues to grow or spread related to treatment._In medicine, an improvement related to treatment._Category; used informally to mean a class of things.","longName":"2721443v1.0:2721678v1.1","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2721443","version":"1","preferredName":"Positron Emission Tomography (PET) Assessment Disease Response","preferredDefinition":"The final result of a Positron Emission Tomography (PET) in determinating the extent of  cancer that continues to grow or spread related to treatment.  [Manually-curated]","longName":"PET_ASSESS_DZ_RESP","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2721380","version":"1","preferredName":"Positron Emission Tomography Assessment","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:The final result of a determination of the value, significance, or extent of.","longName":"C17007:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43CDB08C-3359-05C0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-01-15","modifiedBy":"ONEDATA","dateModified":"2008-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2729593","version":"1","preferredName":"Disease Progression Response","preferredDefinition":"Cancer that continues to grow or spread.:In medicine, an improvement related to treatment.","longName":"C17747:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"466FDD70-12C3-5C42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-02-18","modifiedBy":"ONEDATA","dateModified":"2008-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43D77D20-6877-1314-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-01-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"9/13/12 removed ACRIN as origin and caBIG-ACRIN-PET-CDEsCS/CSI; released for COG reuse.  2/18/08 - added concept for disease that was missing.  1/16/07 - created to support ACRIN PET DE curation","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2721678","version":"1.1","preferredName":"Disease Response Category","preferredDefinition":"In medicine, an improvement related to treatment._Category; used informally to mean a class of things.","longName":"DZ_RESP_CAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ND","valueDescription":"No Response","ValueMeaning":{"publicId":"2559542","version":"1","preferredName":"No Response","longName":"2559542","preferredDefinition":"No apparent change or worsening in lesion staging classification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Response","conceptCode":"C123600","definition":"No apparent change or worsening in lesion staging classification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2021-04-28","changeDescription":"Added concept annotation and changed case of Long Name. mc 4/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A42-D7DC-E040-BB89AD43288F","beginDate":"2008-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"PD","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A4C-D7DC-E040-BB89AD43288F","beginDate":"2008-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2570560","version":"1","preferredName":"Partial Response","longName":"2570560","preferredDefinition":"Partial Response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-15","changeDescription":null,"administrativeNotes":"2023.9.15 Alt VM added per ticket request CADSR0002857. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A56-D7DC-E040-BB89AD43288F","beginDate":"2008-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Response","ValueMeaning":{"publicId":"2570187","version":"1","preferredName":"Complete Response","longName":"2570187","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A60-D7DC-E040-BB89AD43288F","beginDate":"2008-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"NE","valueDescription":"Not evaluable","ValueMeaning":{"publicId":"3589199","version":"1","preferredName":"Not evaluable","longName":"3589199","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C99ED3FF-BE29-A9BD-E040-BB89AD43521F","latestVersionIndicator":"Yes","beginDate":"2012-09-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A6A-D7DC-E040-BB89AD43288F","beginDate":"2012-09-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE26D5F4-4A7E-D7DC-E040-BB89AD43288F","beginDate":"2012-09-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"ONEDATA","dateModified":"2012-11-10","deletedIndicator":"No"},{"value":"NU","valueDescription":"No sites of uptake","ValueMeaning":{"publicId":"3589197","version":"1","preferredName":"No sites of uptake","longName":"3589197","preferredDefinition":"No sites of uptake on FDG-PET scan at study entry and scan remains negative","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C99CD941-54E7-D544-E040-BB89AD437A01","latestVersionIndicator":"Yes","beginDate":"2012-09-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE4BDB91-10FC-FDA4-E040-BB89AD435648","beginDate":"2012-09-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-12","modifiedBy":"ONEDATA","dateModified":"2012-11-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2721677","version":"1","preferredName":"Response Category","preferredDefinition":"In medicine, an improvement related to treatment.:Category; used informally to mean a class of things.","longName":"C50995:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43DC57A1-B68C-6CBD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-01-16","modifiedBy":"ONEDATA","dateModified":"2008-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE26D5F4-4A2C-D7DC-E040-BB89AD43288F","latestVersionIndicator":"Yes","beginDate":"2012-11-10","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-10","modifiedBy":"COOPERM","dateModified":"2017-04-11","changeDescription":"11/13/12 jc Released per Wendy Wong/COG.  11/10/12 jc change VM-No sites of update to NU.  9/13/12 removed ACRIN as origin and caBIG-ACRIN-PET-CDEsCS/CSI; revised VD for COG question and released.  1/16/08 - created for ACRIN PET data element","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Semi-Quantitative Assessment:","type":"Preferred Question Text","description":"Semi-Quantitative Assessment: Local-regional disease response","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What type of response was achieved","url":null,"context":"CTEP"}],"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE4BDB91-1106-FDA4-E040-BB89AD435648","latestVersionIndicator":"Yes","beginDate":"2012-11-11","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2012-11-12","modifiedBy":"CHILLIJ","dateModified":"2012-11-13","changeDescription":"11/13/12 jc Released per Wendy Wong/COG.  11/11/12 CDE/VD were versioned to support change of value for \"no sites of uptake\" changed to \"NU\".  9/13/12 removed ACRIN as origin and caBIG-ACRIN-PET-CDEsCS/CSI; revised VD for COG question and released.  1/31/08 - created in support of ACRIN PET data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}